E Therapeutics (ETX)

 

ETX Share PerformanceMore

52 week high13.2500 22/06/17
52 week low6.0000 01/06/17
52 week change -0.3750 (-4.92%)
4 week volume465,841 30/04/18
price7.2500
price date1527163712
close7.3750

Latest NewsMore

Collaboration with C4X Discovery Holdings PLC

Miscellaneous medium priority announcements

Notice of AGM

Notification of a company’s annual general meeting

e-Therapeutics operating losses narrow as R&D spend shrinks

e-Therapeutics said operating losses narrowed to 6.8m in the year to the end of January, from 16.3m in 2016, buoyed by a fa...

Full Year Results

Announcement of full year/4th quarter financial results

Notification of Full Year Results Date

Notification of the date financial results will be published

Director/PDMR Shareholding

e-Therapeutics enters two AI collaborations

e-Therapeutics is to collaborate with Intellegens and Biorelate to enhance and extend its artificial intelligence technology ca...

E-Therapeutics enters two AI collaborations

RNS Number: 8093B e-Therapeutics plc 15 January 2018 e-Therapeutics ('e-Therapeutics' or the 'Company') e-Therapeutics to collaborate with Intellegens and Biorelate to enhance and extend its AI technology capabilities Oxford, UK, 15 January 2018: e-Therapeutics , a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs...

Fundamental DataMore

EPS-4.91
Dividend yield0 %

Latest discussion posts More

  • Q1 2017 blog update - ETX

    Q1 2017 blog weekly ETX chart update - notes under each chart: http://bonker99.com/Blogs
    10-Feb-2017
    Bonker
  • ETX chart

    http://bonker99.com/charts
    6-Feb-2017
    Bonker
  • Results

    RNS available at company's website. although seems to be missing in III ...
    22-Mar-2016
    nk1999

Users' HoldingsMore

Users who hold E Therapeutics also hold..

Codes & Symbols

ISINGB00B2823H99
SymbolsETX, LSE:ETX, ETX.L, ETX:LN, LON:ETX, XLON:ETX